Biomedicines announced another pharma partnership Tuesday, agreeing to work on several protein therapies with the Swiss ...
Biogen and UCB’s gamble on advancing into phase 3 on the back of a failed study looks to have paid off, with the partners ...
Novartis has inked a deal potentially worth more than $1 billion with Flagship-founded Generate:Biomedicines to develop ...
Fusion Micro Finance Ltd, Nava Ltd, SBFC Finance Ltd and Concord Biotech Ltd are among the other losers in the BSE's 'A' group today, 24 September 2024.
Vyloy (zolbetuximab) has been given the go-ahead for use in combination with chemotherapy for the first-line treatment of ...
The Daily Yonder on MSN18m
Empowering Rural Entrepreneurs to Drive the Rural Economic RevivalImagine a rural past with agriculture, manufacturing and a wealth of natural resources working together to fuel the local ...
Since inception return is not available for indices created subsequent to the date shown. Returns quoted are past performance and do not guarantee future results; current performance may be lower or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback